TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MEDTRONIC Share Price

Certificat

DE000SN2N7B5

Market Closed - Deutsche Boerse AG 01:07:46 01/06/2024 am IST
1.53 EUR -1.29% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MEDTRONIC
1 month-3.77%
3 months+15.04%
Date Price Change
31/24/31 1.53 -1.29%
30/24/30 1.55 +6.90%
29/24/29 1.45 +2.11%
28/24/28 1.42 +3.65%
27/24/27 1.37 -4.20%

Delayed Quote Deutsche Boerse AG

Last update May 01, 2024 at 01:07 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SN2N7B
ISINDE000SN2N7B5
Date issued 30/05/2022
Strike 97.23 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.74
Lowest since issue 0.24

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.37 USD
Average target price
94.07 USD
Spread / Average Target
+15.61%
Consensus